The invention relates to a device for placement in an environment for delivery of medication to said environment, comprising a reservoir having an orifice, a conveying unit for conveying a reservoir's content through the orifice and an actuator arrangement for driving the conveying unit. The invention further relates to a capsule provided with the device for placement in an environment to deliver medication to said environment.
In WO 94/07562 delivery capsules are disclosed which include a beneficial agent and an activating mechanism, which delivery capsules are designed to deliver the beneficial agent in a pulsatile manner through the orifice. The pulsatile delivery is achieved by a pair of guide members inside the capsule, one secured to the capsule itself and the other to a movable partition.
Techniques disclosed in WO 94/07562 have limited ability to deliver a powder like medication in a humid environment to said environment since the techniques have no facility to annul a solidification of the powder like medication induced by humidification.
It is an object of the invention to provide a device for a more reliable delivery of a medication in a humid environment.
The object of the invention is achieved by the device according to the invention which is characterized in that the conveying unit comprises an auger extending in the reservoir. By extending the auger in the reservoir, mechanical interaction with the reservoir's content is arrived at. As a result of the presence of at least a portion of the auger in the reservoir, in addition to conveying the powder like medication to the orifice of the reservoir, a solidification of a powder like medication contained in the reservoir through humidification in a moist environment or by way of a humidity already contained in the powder, is annulled through pulverization. Here, solidification of the powder like medication ranges from a wet paste to a solid. It is noted that the actuator arrangement can include one or more actuators known per se, such as a spring actuator, an electromagnetic actuator, a hydraulic actuator or a piezoelectric actuator. The auger can be made from a biocompatible plastic or a stainless steel.
In a preferred embodiment according to the invention, the conveying unit comprises a piston for pressurizing the reservoir's content. With that, under the pressure provided by the piston, the reservoir's content is continuously fed into an auger's helical flighting. As a result, a revolution of the auger eventuates at a well defined amount of powder like medication conveyed through the orifice.
In a further embodiment according to the invention, the conveying unit is provided with a facility for pretensioning the piston to the reservoir's content. As a result, a continuous energizing of the actuator arrangement for pressurizing the reservoir's content is not needed.
In a further embodiment according to the invention, the piston is driveable by the auger. As a result, the prerequisite for a further actuator to drive the piston is circumvented.
In an embodiment according to the invention a surface profile of the piston matches a profile of a reservoir's surface adjacent to or surrounding the orifice. As a result the residual reservoir's content is minimized. With that the yield of a capsule provided with this embodiment according to the invention is maximized.
In a further embodiment according to the invention, the conveying unit comprises a collapsible barrier for pressurizing the reservoir's content. The collapsible barrier is conformable to a curved surface of revolution enveloping the auger. By selecting the dimensions of the curved surface of revolution enveloping the auger to be sufficiently small, a residual reservoir's content is minimized. With that a yield of a capsule provided with this embodiment according to the invention is maximized.
In a further embodiment according to the invention, the auger has an axially varying helical flighting height. Herein the helical flighting height is defined as a radius measured from an auger's axis of revolution to a curved surface of revolution enveloping the auger.
In an embodiment according to the invention, the axially varying helical flighting height increases with an axial distance measured from the orifice. As a result, an axially oriented pressure gradient can be exerted by the auger on the reservoir's content contained within a volume established by a revolution of the auger. The helical flighting height preferably monotonically increases with the distance from the orifice. Proximal to the orifice, the helical flighting height matches a size of the orifice with the purpose of continuation of the auger up to and including the reservoir's orifice.
In an embodiment according to the invention the auger has an axially varying helical flighting pitch. In this text, the helical flighting pitch is defined as an axial distance covered by a complete turn of the helical flighting.
In a further embodiment according to the invention the helical flighting pitch increases with the axial distance measured from the orifice. As a result, an axially oriented pressure gradient can be exerted by the auger on the reservoir's content contained within the volume established by a revolution of the auger. Preferably, the helical flighting pitch monotonically increases with the distance from the orifice.
In a further embodiment according to the invention the device comprises a measuring apparatus for measuring a quantity of the reservoir's content conveyed through the orifice. Based on a measurement acquired by way of the measuring apparatus, the actuator arrangement can be controlled. As a result, a more accurate dosing of powder like medication to an environment is obtained.
In an embodiment according to the invention the measuring apparatus comprises a revolution counter for counting a number of revolutions made by the auger. Assuming that the helical flighting height and the helical flighting pitch are both known, the number of revolutions made by the auger provides an accurate measurement for the amount of the reservoir's content conveyed through the orifice.
The capsule according to the invention is defined in claim 13. The capsule can be made of any suitable material, such as a biocompatible plastic. Apart from being non-reactive to a medication or an acid, a biocompatible plastic material has a density which is larger than water which will ensure the capsule neither to float above water nor to be detained inside a gastrointestinal tract.
The invention is highly suitable for application in the field of targeted and precisely controlled delivery of a medication, especially a powder like medication, to an environment, particularly a humid environment, which environment may be inside a human or an animal body. A likely environment is a gastrointestinal tract.
The invention and its advantages are further elucidated by way of example with reference to the drawings in which:
While the invention has been illustrated and described in detail in the drawings and in the foregoing description, the illustrations and the description are to be considered illustrative or exemplary and not restrictive. The invention is not limited to the disclosed embodiments. It is noted that the apparatus according to the invention and all its components can be made by applying processes and materials known per se. In the set of claims and the description the word “comprising” does not exclude other elements and the indefinite article “a” or “an” does not exclude a plurality. Any reference signs in the claims should not be construed as limiting the scope. It is further noted that all possible combinations of features as defined in the set of claims are part of the invention.
Applicants claim the benefit of International Application Number PCT/IB2009/052575, filed Jun. 17, 2009, and Provisional Application Ser. No. 61/073,778, filed Jun. 19, 2008.
Filing Document | Filing Date | Country | Kind | 371c Date |
---|---|---|---|---|
PCT/IB2009/052575 | 6/17/2009 | WO | 00 | 11/12/2010 |
Publishing Document | Publishing Date | Country | Kind |
---|---|---|---|
WO2009/153739 | 12/23/2009 | WO | A |
Number | Name | Date | Kind |
---|---|---|---|
4572403 | Benaroya | Feb 1986 | A |
4814180 | Eckenhoff et al. | Mar 1989 | A |
5071040 | Laptewicz, Jr. | Dec 1991 | A |
5279607 | Schentag et al. | Jan 1994 | A |
5318557 | Gross | Jun 1994 | A |
5423779 | Yeh | Jun 1995 | A |
5567592 | Benet et al. | Oct 1996 | A |
6053899 | Slanda et al. | Apr 2000 | A |
6423779 | Sue et al. | Jul 2002 | B2 |
6632216 | Houzego et al. | Oct 2003 | B2 |
6699214 | Gellman | Mar 2004 | B2 |
6803373 | Schellens | Oct 2004 | B2 |
6929636 | von Alten | Aug 2005 | B1 |
7014640 | Kemppainen et al. | Mar 2006 | B2 |
7030132 | Schellens et al. | Apr 2006 | B2 |
8021357 | Tanaka et al. | Sep 2011 | B2 |
8100889 | Kawano et al. | Jan 2012 | B2 |
8308681 | Slocum et al. | Nov 2012 | B2 |
20020072735 | Kupperblatt et al. | Jun 2002 | A1 |
20030020810 | Takizawa et al. | Jan 2003 | A1 |
20030213495 | Fujita et al. | Nov 2003 | A1 |
20040054278 | Kimchy et al. | Mar 2004 | A1 |
20040242962 | Uchiyama | Dec 2004 | A1 |
20050147559 | von Alten | Jul 2005 | A1 |
20050234431 | Williams et al. | Oct 2005 | A1 |
20060145876 | Kimura et al. | Jul 2006 | A1 |
20060155174 | Glukhovsky et al. | Jul 2006 | A1 |
20070138027 | Dinsmoor et al. | Jun 2007 | A1 |
20070213659 | Trovato et al. | Sep 2007 | A1 |
20070250045 | Trieu | Oct 2007 | A1 |
Number | Date | Country |
---|---|---|
1958090 | May 2007 | CN |
100998905 | Jul 2007 | CN |
3317536 | Nov 1984 | DE |
3317536 | Nov 1984 | DE |
3339323 | May 1985 | DE |
2794654 | Dec 2000 | FR |
2374149 | Sep 2002 | GB |
2002532162 | Oct 2002 | JP |
2003520108 | Jul 2003 | JP |
WO9407562 | Apr 1994 | WO |
WO0152923 | Jul 2001 | WO |
WO03008637 | Jan 2003 | WO |
WO03068061 | Aug 2003 | WO |
WO2004066903 | Aug 2004 | WO |
WO2005025647 | Mar 2005 | WO |
WO2005038049 | Apr 2005 | WO |
WO2006021932 | Mar 2006 | WO |
WO2006025013 | Mar 2006 | WO |
WO2006037434 | Apr 2006 | WO |
WO2006044049 | Apr 2006 | WO |
WO2006056944 | Jun 2006 | WO |
WO2006077529 | Jul 2006 | WO |
WO2008029372 | Mar 2008 | WO |
WO2008038199 | Apr 2008 | WO |
WO2008062335 | May 2008 | WO |
Entry |
---|
Chinese Office Action mailed Jan. 15, 2013 for Chinese patent application No. 201080015953.5, a counterpart foreign application of U.S. Appl. No. 13/262,841, 17 pages. |
Chinese Office Action mailed Jan. 21, 2013 for Chinese patent application No. 201080040663.6, a counterpart foreign application of U.S. Appl. No. 13/390,111, 8 pages. |
Chinese Office Action mailed Mar. 14, 2013 for Chinese patent application No. 200980112018.8, a counterpart foreign application of U.S. Appl. No. 12/933,891, 12 pages. |
Chinese Office Action mailed May 13, 2013 for Chinese patent application No. 201080015284.1, a counterpart foreign application of U.S. Appl. No. 13/262,861, 11 pages. |
Evans, et al., “Measurement of Gastrointestinal pH Profiles in Normal Ambulant Human Subjects”, GUT, vol. 29, 1988, pp. 1035-1041. |
Japanese Office Action mailed Apr. 16, 2013 for Japanese Patent Applicaiton No. 2011-514179, a counterpart foreign application of U.S. Appl. No. 12/992,305, 9 pages. |
Japanese Office Action mailed Apr. 30, 2013 for Japanese patent application No. 2010-546431, a counterpart foreign application of U.S. Appl. No. 12/867,888, 4 pages. |
Kompella, et al., “Delivery System for Penetration Enhancement of Peptide and Protein Drugs: Design Considerations”, Advanced Drug Delivery Reviews, vol. 46, 2001, pp. 211-245. |
Paine, et al., “Characterization of Interintestinal and Intraintestinal Variations in Human CYP3A-Dependent Metabolism”, The Journal of Pharmacology and Experimental Therapeutics, vol. 283, No. 3, 1997, pp. 1552-1562. |
Siccardi, et al., “Regulation of Intestinal Epithelial Function: A Link Between Opportunities for Macromolecular Drug Delivery and Inflammatory Bowel Disease”, Advanced Drug Delivery Reviews, vol. 57, 2005, pp. 219-235. |
Number | Date | Country | |
---|---|---|---|
20110106064 A1 | May 2011 | US |
Number | Date | Country | |
---|---|---|---|
61073778 | Jun 2008 | US |